16型人乳头瘤病毒衣壳蛋白在真核细胞中的表达

为了构建HPV16型晚期蛋白重组杆状病毒,并使其在昆虫细胞中获得高效表达.首先构建2株重组杆状病毒转移质粒,分别携带人乳头瘤病毒晚期基因L1及L1和L2,再用线性化的杆状病毒DNA与该重组杆状病毒转移质粒共转染sf9昆虫细胞进行同源重组,获得2株重组杆状病毒.经鉴定该重组病毒中有目的基因存在且可表达所编码的L1或L2晚期蛋白.结果表明HPV16型晚期蛋白在昆虫细胞中获得成功表达,为HPV16型预防性基因工程亚单位疫苗的研制和诊断试剂的研究开发奠定了基础.     

杆状病毒表达系统的改进及IL-6在昆虫细胞内的表达和纯化

使用同源重组方法,在昆虫细胞内将多角体启动子驱动的EGFP表达盒插入杆状病毒穿梭载体Bacmid的p74位相,经5轮空斑纯化获得重组穿梭载体Bacmid-egfp。然后将Bacmid-egfp转化含转座助手质粒的E.coliDH10B,获得受体菌E.coliDH10Bac-egfp,由于Bacmid-egfp保留了完整的转座结构和α互补功能,因此该菌株和原始E.coliDH10Bac一样能有效的利用各种pFastBac系列的载体进行转座并构建出能指示病毒繁殖和目的基因表达的重组病毒。使用红色荧光蛋白DsRed对系统进行了验证,结果表明重组病毒Bac-egfp-DsRed感染的细胞中绿色荧光蛋白和红色荧光蛋白均得到了高效表达。进一步使用该系统在昆虫细胞中高效表达并纯化了IL-6蛋白,为研究和应用该细胞因子提供物质基础,同时也进一步证明所改造的杆状病毒表达系统的可靠性和实用性。     

一种构建重组杆状病毒的简易方法

对传统构建重组杆状病毒的方法作了如下改进：先用磷酸钙共沉淀法单独将质粒DNA转进昆虫Sf细胞中,其中重组质粒采用聚乙二醇沉淀法纯化,12～24h后再用低剂量的病毒攻击细胞．改进后的方法简便、省时、经济、重组率高,适于一般实验室使用．     

重组昆虫杆状病毒构建和筛选技术进展

昆虫杆状病毒作为高效的真核表达载体,现已广泛应用于各种外源目的基因的表达。但由于重组病毒产生的比例很低（通常只有0.1%～1%）,成为制约该系统应用的技术瓶颈。本文概括了近年来发展的重组病毒的构建和筛选方法,主要介绍了杆状病毒的线性化技术和利用大肠杆菌-昆虫细胞穿梭载体构建并筛选重组杆状病毒的技术进展。     

外源基因在昆虫杆状病毒表达系统中的表达

随着杆状病毒载体和筛选方法的不断改进,通过Bac-to-Bac方法可以使杆状病毒最大重组率达到100%,缩短了构建重组载体的时间,极大提高了工作效率。另外,研究者开发了一些新的宿主域扩大的昆虫杆状病毒载体,能够在家蚕或蛹内进行高水平表达重组蛋白。昆虫杆状病毒表达系统具有完备的翻译后加工修饰功能和高效表达外源蛋白的能力等特点,是一种非常理想的真核表达系统。利用该表达系统现已成功表达了约千种外源蛋白。以重组杆状病毒为载体的昆虫表达系统、外源基因在该表达系统中的表达情况及在农业领域中的应用进行了介绍。     

小鼠干扰素-γ诱生单核因子在昆虫细胞中的高效表达及其血管生成抑制作用

干扰素 - γ诱生单核因子 (monokine induced by interferon- γ, MIG , CXCL9) 是一种具有趋化 T 淋巴细胞 NK 细胞的 CXC 趋化因子家族成员之一 . 通过 RT-PCR 技术从小鼠脑组织中克隆了小鼠 MIG cDNA ,利用 Bac-to-Bac 杆状病毒表达系统构建了 MIG 重组杆状病毒,并在 Tn-5B1-4 昆虫细胞内将其进行了表达,最后对表达产物进行了纯化和活性鉴定 . 结果显示：小鼠 MIG 蛋白在 Bac-to-Bac 杆状病毒表达系统中可得到高效分泌性表达;分泌到培养上清中的重组 MIG 蛋白经 S-Sepharose 纯化后得到的 MIG 蛋白纯度约为 90% ,产量为 10 mg/L;在 SDS- 聚丙烯酰胺凝胶电泳和蛋白质印迹分析中该蛋白质分子质量显示为 14.4 ku 左右;该纯化蛋白在体外具有诱导 CTLL-2 淋巴细胞钙离子内流和抑制血管内皮细胞迁移和增值的活性,在鸡胚尿囊膜实验中小鼠重组 MIG 具有抑制新血管生成的功能 . 实验表明,在杆状病毒系统中高效表达的小鼠重组 MIG 蛋白具有抑制内皮细胞迁移、增殖和血管生成活性,为今后进一步研究其血管生成抑制活性的机理和将其应用于肿瘤血管抑制实验建立了基础 .     

静水椎螺乙酰胆碱结合蛋白在Bac-to-Bac系统中的表达、纯化与结晶

表达、纯化静水椎螺(Lymnaea stagnalis)乙酰胆碱结合蛋白(Ls-AChBP)并得到晶体。将静水椎螺乙酰胆碱结合蛋白cDNA序列克隆到表达载体pFastBac1上,构建了重组表达质粒pFastBac1-Ls-AChBP-His,经重组子筛选,得到重组杆状病毒质粒Bacmid,采用CellfectinⅡ脂质体,把带有外源基因的杆状病毒质粒Bacmid转染到昆虫细胞中,经镍柱和凝胶色谱柱对重组蛋白进行纯化得到五聚体,并用机器人进行结晶筛选获得其蛋白晶体。重组蛋白Ls-AChBP在Bac-to-Bac表达系统中得到高效表达并被纯化,结晶筛选得到晶体。     

构建基于杆状病毒的BV-T7杂合表达体系及利用其在哺乳动物和禽类细胞中表达eGFP基因

【目的】研究重组杆状病毒BV-T7杂合表达体系能否有效转导禽类细胞并在禽类细胞中表达外源基因(eGFP),从而构建能在禽类细胞中高效稳定表达外源基因的重组杆状病毒表达系统。【方法】本研究利用Bac-to-Bac杆状病毒表达系统,结合T7表达系统,通过对eGFP表达水平的调控来把握噬菌体T7 RNA聚合酶(T7 RNAP)的功能。利用两支重组杆状病毒,pFastBac-CMV-T7 RNAP重组杆状病毒为哺乳动物细胞启动子CMV调控的噬菌体T7 RNA聚合酶的cDNA;pFB-T7pro-IRES-GFP-T7ter重组杆状病毒为T7启动子控制的eGFP报告基因。将两支重组杆状病毒共同侵染哺乳动物OL(oligodendrocyte)细胞、鸡胚成纤维细胞和鸡胚骨骼肌细胞。【结果】两支重组杆状病毒利用T7启动子和T7 RNAP,在OL细胞、鸡胚成纤维细胞和鸡胚骨骼肌细胞中成功表达eGFP报告基因,而且未引起细胞病变,但在鸡胚原代细胞中eGFP的表达相对弱于在OL细胞中的表达。在OL细胞中重组杆状病毒对细胞的转导效率为59.5%,在鸡胚成纤维细胞和鸡胚骨骼肌细胞中转导效率分别为23.2%和33.1%。【结论】本研究构建的基于杆状病毒、T7RNA聚合酶、T7启动子(BV-T7)杂合表达体系能够在哺乳类细胞及禽类细胞中表达T7 RNAP,并利用T7RNAP继续高效而稳定地表达外源基因。这为难于体外操作的RNA病毒提供了有效的研究方法,并对新型基因工程疫苗的研制提供了一个高效而稳定的表达载体系统。     

不同脊髓灰质炎病毒株3CD蛋白酶在昆虫细胞中的表达及其对P1前体蛋白的剪切

目的获得在昆虫细胞中有效表达脊髓灰质炎病毒P1基因和3CD基因的重组杆状病毒,为制备脊髓灰质炎病毒样颗粒疫苗提供了科学依据。方法将I型脊髓灰质炎病毒(Mahoney株)的P1基因和3CD基因构建到供体质粒中,通过flash BAC ULTRATM系统制备重组杆状病毒;将Mahoney株的P1基因与Sabin株Ⅲ型的3CD基因组合,用同样方法构建重组杆状病毒。通过接种昆虫细胞草地贪夜蛾细胞(sf-9细胞)对两种病毒进行扩增,再接种昆虫细胞粉纹夜蛾细胞(High five细胞)扩大培养,并通过定量PCR对P1和3CD基因的表达进行验证,利用Western blot检测P1蛋白的表达及被3CD蛋白酶剪切的情况。结果获得了两株稳定表达脊髓灰质炎病毒P1和3CD基因的重组杆状病毒。其中,重组杆状病毒(Bac U-Mahoney-P1-3CD)在感染细胞后,3CD蛋白酶表达量较低,不能有效剪切P1前体蛋白;而重组杆状病毒(Bac U-Mahoney-P1-Sabin PV3 3CD)感染细胞后,3CD蛋白酶的表达量和对P1前体蛋白的剪切效力都有明显提高(P<0.05)。结论将Mahoney株P1基因和Sabin株Ⅲ型的3CD基因的组合构建重组杆状病毒,可有效地在昆虫细胞中表达P1和3CD基因,并且Sabin株Ⅲ型的3CD蛋白酶可有效地剪切Mahoney株的P1前体蛋白。     

豌豆Lhcb2基因在大肠杆菌中的高效表达及其表达产物与色素的重组

将豌豆的Lhcb2基因亚克隆至原核表达载体pET-3d上, 通过定点突变使其在大肠杆菌BL21 (DE3)中得到高效表达, 其表达量约占大肠杆菌总蛋白的40%, 经纯化后获得电泳纯的Lhcb2蛋白. 采用改进的液氮/室温冻融的重组方法将纯化的蛋白与色素进行重组, 建立了高效的重组系统. 重组后所获得的LHCB2单体与天然的LHCⅡ单体相比, 其在部分变性胶的电泳行为、低温荧光发射光谱和激发光谱, 以及室温吸收光谱等方面都非常相似, 说明大量表达的Lhcb2蛋白与色素已成功地重组, 并具有与天然LHCⅡ单体相类似的组成和结构.     

Improving baculovirus recombination

Recombinant baculoviruses have established themselves as a favoured technology for the high-level expression of recombinant proteins. The construction of recombinant viruses, however, is a time consuming step that restricts consideration of the technology for high throughput developments. Here we use a targeted gene knockout technology to inactivate an essential viral gene that lies adjacent to the locus used for recombination. Viral DNA prepared from the knockout fails to initiate an infection unless rescued by recombination with a baculovirus transfer vector. Modified viral DNA allows 100% recombinant virus formation, obviates the need for further virus purification and offers an efficient means of mass parallel recombinant formation.     

A Highly Efficient and Simple Construction Strategy for Producing Recombinant Baculovirus Bombyx mori Nucleopolyhedrovirus

The silkworm baculovirus expression system is widely used to produce recombinant proteins. Several strategies for constructing recombinant viruses that contain foreign genes have been reported. Here, we developed a novel defective-rescue BmNPV Bacmid (reBmBac) expression system. A CopyControl origin of replication was introduced into the viral genome to facilitate its genetic manipulation in Escherichia coli and to ensure the preparation of large amounts of high quality reBmBac DNA as well as high quality recombinant baculoviruses. The ORF1629, cathepsin and chitinase genes were partially deleted or rendered defective to improve the efficiency of recombinant baculovirus generation and the expression of foreign genes. The system was validated by the successful expression of luciferase reporter gene and porcine interferon γ. This system can be used to produce batches of recombinant baculoviruses and target proteins rapidly and efficiently in silkworms.     

In vitro and in vivo gene delivery by recombinant baculoviruses

Although recombinant baculovirus vectors can be an efficient tool for gene transfer into mammalian cells in vitro, gene transduction in vivo has been hampered by the inactivation of baculoviruses by serum complement. Recombinant baculoviruses possessing excess envelope protein gp64 or other viral envelope proteins on the virion surface deliver foreign genes into a variety of mammalian cell lines more efficiently than the unmodified baculovirus. In this study, we examined the efficiency of gene transfer both in vitro and in vivo by recombinant baculoviruses possessing envelope proteins derived from either vesicular stomatitis virus (VSVG) or rabies virus. These recombinant viruses efficiently transferred reporter genes into neural cell lines, primary rat neural cells, and primary mouse osteal cells in vitro. The VSVG-modified baculovirus exhibited greater resistance to inactivation by animal sera than the unmodified baculovirus. A synthetic inhibitor of the complement activation pathway circumvented the serum inactivation of the unmodified baculovirus. Furthermore, the VSVG-modified baculovirus could transduce a reporter gene into the cerebral cortex and testis of mice by direct inoculation in vivo. These results suggest the possible use of the recombinant baculovirus vectors in combination with the administration of complement inhibitors for in vivo gene therapy.     

Baculoviruses: diversity,evolution and manipulation of insects

Baculoviruses, members of the family Baculoviridae, are large, enveloped viruses that contain a double‐stranded circular DNA genome of 80–180 kbp, encoding 90–180 putative proteins. These viruses are exclusively pathogenic for arthropods, particularly insects, and have been developed, or are being developed, as environmentally sound pesticides and eukaryotic vectors for foreign protein expression, surface display, gene delivery for gene therapy, vaccine production and drug screening. The baculoviruses contain a set of approximately 30 core genes that are conserved among all baculovirus genomes sequenced to date. Individual baculoviruses also contain a number of lineage‐ or species‐specific genes that have greatly impacted the diversification and evolution of baculoviruses. In this review, we first describe the general properties and biology of baculoviruses and then focus on the baculovirus genes and mechanisms involved in the replication, spread and survival of baculoviruses within the context of their diversity, evolution and insect manipulation.     

Silkworm, Bombyx mori larvae expressed the spider silk protein through a novel Bac-to-Bac/BmNPV baculovirus

Abstract:  The silkworm has become an ideal multicellular eukaryotic model system for basic research. The major advantages of expressing foreign genes in silkworm larvae are the low cost of feeding, the extremely high levels of expression achievable compared with expression in cell lines and increased safety because the baculovirus is noninfectious to vertebrates. In this study, we used a recently developed Bombyx mori Nucleopolyhedrovirus (BmNPV) bacmid to express the spider flagelliform silk gene in silkworm larvae. The recombinant bacmid baculoviruses (rBacmid/BmNPV/Flag) were introduced into the first-day larvae of the fifth instar by subcutaneous injection. The worms presented symptoms typical of NPV infection from 72 h after injection compared with control. The haemolymph was collected from the infected larvae 120 h post-infection and the recombinant 6× His-tagged Flag protein was purified by the Ni-NTA spin kit under denaturing conditions with 8  m urea. A 37.0-kDa protein was visualized both in rBacmid/BmNPV/Flag-infected haemolymph and eluting fraction. The results showed that the Bac-to-Bac/BmNPV baculovirus expression system is an efficient tool to express the target gene in silkworm larvae, which takes only 7–10 days for generating recombinant baculovirus, compared with the traditional homologous recombination method, which needs at least 40 days for multiple rounds of purification and amplification of viruses.     

Replication inhibition by nucleoside analogues of a recombinant Autographa californica multicapsid nuclear polyhedrosis virus harboring the herpes thymidine kinase gene driven by the IE-1(0) promoter: a new way to select recombinant baculoviruses.

The expression of the thymidine-thymidylate kinase (HSV1-TK), (ATP: thymidine 5'-phosphotransferase; EC 2.7.1.21) of herpes simplex virus type 1 endows the host cell with a conditional lethal phenotype which depends on the presence of nucleoside analogues metabolized by this enzyme into toxic inhibitors of DNA replication. To generate a recombinant baculovirus that could be selected against by nucleoside analogs, the HSV1-tk coding sequence was placed under the control of the Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV) immediate early promoterm IE-1(0), and this construction was introduced via homologous recombination into the polyhedrin locus of AcMNPV. Two recombinant baculoviruses harboring this gene construct at the polyhedrin locus were isolated and tested for their ability to replicate in the presence of various concentrations of the nucleoside analog 9-(1,3-Dihydroxy-2-propoxymethyl)guanine (Ganciclovir). Neither Sf9 lepidopteran cell viability nor replication of wild type or beta-Galactosidase-expressing recombinant AcMNPVs were affected by concentrations of Ganciclovir up to 100 microM. In contrast, replication of the recombinant AcMNPV virus harboring the HSV1-tk gene was inhibited by Ganciclovir in a dose-dependent manner. The inhibition was detectable at 2 microM and complete at 100 microM. This property was exploited in model isolations aimed at purifying new recombinant viruses having lost this counter-selectable gene marker as a result of homologous recombination at the polyhedrin locus after cotransfection of the viral DNA with a replacement vector. After being propagated in the presence of Ganciclovir, the progeny of such co-transfections contained over 85% recombinant viruses, demonstrating that counter-selection of parental HSV1-tk-containing viruses by Ganciclovir constitutes a novel approach for recombinant baculovirus isolation.     

Structural divergence among genomes of closely related baculoviruses and its implications for baculovirus evolution

Baculoviruses are members of a large, well-characterized family of dsDNA viruses that have been identified from insects of the orders Lepidoptera, Hymenoptera, and Diptera. Baculovirus genomes from different virus species generally exhibit a considerable degree of structural diversity. However, some sequenced baculovirus genomes from closely related viruses are structurally very similar and share overall nucleotide sequence identities in excess of 95%. This review focuses on the comparative analysis of partial and complete nucleotide sequences from two groups of closely related baculoviruses with broad host ranges: (a) group I multiple nucleopolyhedroviruses (MNPVs) from a cluster including Autographa californica (Ac)MNPV, Rachiplusia ou (Ro)MNPV, and Plutella xylostella (Plxy)MNPV; and (b) granuloviruses (GVs) from a cluster including Xestia c-nigrum (Xecn)GV and Helicoverpa armigera (Hear)GV. Even though the individual viruses in these clusters share high nucleotide sequence identities, a significant degree of genomic rearrangement (in the form of insertions, deletions, and homologous recombination resulting in allelic replacement) is evident from alignments of their genomes. These observations suggest an important role for recombination in the early evolution and biological characteristics of baculoviruses of these two groups.     

Improved generation of recombinant baculovirus genomes in Escherichia coli

An improved method for the generation of recombinant baculoviruses by Tn7-mediated transposition is described. The method is based on the modified donor vector (pBVboost) and an improved selection scheme of the baculovirus bacmids in Escherichia coli with a mutated SacB gene. Recombinant bacmids can be generated at a frequency of ~10⁷/µg of donor vector with a negligible background. This easy-to-use and efficient pBVboost system provides the basis for a high-throughput generation of recombinant baculoviruses as well as a more convenient way to produce single viruses. The introduced selection scheme is also useful for the construction of other vectors by transposition in E.coli.     

Impact of Recombinant Baculovirus Applications on Target Heliothines and Nontarget Predators in Cotton

Recombinant baculoviruses have been genetically engineered to reduce the time to kill infected pests, thus reducing crop damage. In this study, wild-type viruses and recombinant viruses expressing a scorpion toxin were applied to cotton in response to larval infestations of Helicoverpa zea and Heliothis virescens in 1997 and 1998. A chemical standard and an untreated control acted as comparison treatments. The goals of this field study were to (1) assess the efficacy of recombinant baculoviruses in protecting cotton from larval feeding damage; (2) assess the impact of recombinant virus introductions on predator densities and diversity; and (3) determine if cotton predators acquire baculovirus by consuming infected heliothines. When applications were timed at larval emergence, certain recombinant virus treatments protected cotton from damage better than wild-type virus treatments and as well as the chemical standard. Differences in efficacy between recombinant and wild-type baculoviruses were not apparent if treatments were applied 3 to 4 days after peak larval emergence. Predator densities and diversity were similar among recombinant and wild-type baculovirus treatments, whereas plots treated with the chemical standard had consistently smaller predator populations. From polymerase chain reaction analyses of predators in 1997 and 1998, 1.7 and 0.2%, respectively, of predators had consumed a virus-infected heliothine. Nine of the 26 predators carrying viral DNA were positive for recombinant virus. Additionally, 13 of the 26 predators were found to disperse 13.5 to 105 m 2 to 5 days after initial virus applications. Five of these dispersing predators (0.2% of all predators evaluated) carried recombinant viral DNA. These results suggest that the potential for the inadvertent spread of recombinant viral DNA via dispersing predators is low.     

重组杆状病毒杀虫剂的生物安全性

分别就重组杆状病毒杀虫剂对捕食性天敌和寄生性天敌的影响、与其它生物间的基因重组和生态效应等问题进行了综述。研究成果表明,重组病毒的生态适应性降低,因而对生态环境以及捕食性和寄生性天敌等非靶标生物种类的危险性也大大降低。但重组病毒也不是绝对安全的,对其生物安全性还要进行长期、深入全面地分析和研究。